Enveda Raises $311M Series E at $2B Valuation

Enveda raised a $311 million Series E at a $2 billion valuation, double its valuation 12 months ago. The round, reported Sept. 23, was led by Catalio Capital Management with Iconiq participating. The clinical-stage biotech, founded in 2019 by Viswa Colluru, uses AI to discover drugs from plants and microbes and has multiple candidates in human trials.